Cargando…
Pancreatic islet organoids-on-a-chip: how far have we gone?
Diabetes mellitus (DM) is a disease caused by dysfunction or disruption of pancreatic islets. The advent and development of microfluidic organoids-on-a-chip platforms have facilitated reproduce of complex and dynamic environment for tissue or organ development and complex disease processes. For the...
Autores principales: | Yin, Jiaxiang, Meng, Hao, Lin, Jingfang, Ji, Wei, Xu, Tao, Liu, Huisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238112/ https://www.ncbi.nlm.nih.gov/pubmed/35764957 http://dx.doi.org/10.1186/s12951-022-01518-2 |
Ejemplares similares
-
Prevention of diabetes: How far have we gone?
por: Ramachandran, Ambady, et al.
Publicado: (2014) -
Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
por: Gajjela, Harini, et al.
Publicado: (2021) -
Nonoperative management of high degree hepatic trauma in the patient with risk factors for failure: have we gone too far?
por: Beuran, M, et al.
Publicado: (2010) -
The Endothelial Glycocalyx as a Target of Ischemia and Reperfusion Injury in Kidney Transplantation—Where Have We Gone So Far?
por: Duni, Anila, et al.
Publicado: (2021) -
Paediatric Surgery on the African Continent: How Far Have We Come; How Far Can We Go?
por: Numanoglu, Alp
Publicado: (2023)